Tissue Chip

hesperos

Dr. Shuler’s “UniChip enables long-term recirculating unidirectional perfusion with gravity-driven flow for microphysiological systems” has been selected by the handling Editor as one of the top 10% of papers published in Lab on a Chip. This selection … Read More

hesperos

ORLANDO, FLA – April 25, 2018 — Hesperos, Inc. has increased its pioneering human-on-a-chip drug testing capabilities by adding a new in vitro, human-human neuromuscular model to its patented multi-organ microfluidic device systems. Abnormal function of … Read More

shuler

Getting drugs past the neuroprotective blood-brain barrier (BBB) has been a perplexing problem and formidable challenge for researchers and pharmaceutical companies alike. Hesperos’s creation of a microfluidic model capable of mimicking in vivo characteristics of the … Read More

hesperos

The challenge: Build microfluidic devices that can keep cells alive in a setting that mimics specific organs or tissues, and incorporate biosensors to measure the cells’ physiology. The goal: Mimic diseases and test drug responses that … Read More

slas

For the second year in a row, SLAS Technology has chosen the article “TEER Measurement Techniques for In Vitro Barrier Model Systems”, co-authored by Dr. Hickman and Dr. Shuler,  for the 2018 SLAS Technology Authors Choice Award. This award reflecting … Read More

shuler

Congratulations to Dr. Shuler for winning the 2018 BMES SMBE Shu Chien Acheivement Award! The BioMedical Engineering Society (BMES) Cellular and Molecular Bioengineering (CMBE) Shu Chien Achievement Award was established in 2014 through an endowment by … Read More

shuler

Hesperos president Michael Shuler first coined the term “animal-on-a-chip” (and now “human-on-a-chip”) back in 1990.  Starting as part of his research to define the multidisciplinary field, human-on-a-chip systems are quickly becoming an industry destined drastically reduce … Read More